Voices
Gerry Hanna
Trinity College Dublin/LinkedIn

Gerry Hanna: Should SABR Dose/Fractionation Be Standardized in Lung Cancer Treatment?

Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared on X about a recent paper by Salem Alfaifi et al. published on The Red Journal:

“Alfaifi et al, report in the IJROBP – The Red Journal a range of SABR dose/fractionation schedules are used in the treatment of lung cancer across the Variation in practice exists, but is impactful clinically? Should we standardise Dose/Fx and how sould be approach this?”

Gerry Hanna

Title: International Patterns of Practice for SABR for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?

Authors: Salem Alfaifi, Alexander V. Louie, Shankar Siva, Matthias Guckenberger, Gregory M.M. Videtic, Kristin A. Higgins, Faiz Alshafa, Hamza AlGhamdi, Erin F. Gillespie, Kevin Stephans, Layth Mula-Hussain, Stephen Harrow, David A. Palma

Read the full article.

Gerry Hanna

More insight about Lung Cancer.

Alexander V Louie cancer cancer treatment David A. Palma Erin F Gillespie Faiz Alshafa Gerry Hanna Gregory M. M. Videtic Hamza AlGhamdi IJROBP Kevin Stephans Kristin A. Higgins Layth Mula-Hussain Lung cancer Matthias Guckenberger OncoDaily Oncology SABR Salem Alfaifi Shankar Siva Stephen Harrow